Compare OBDC & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBDC | SHC |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.4B |
| IPO Year | 2015 | 2020 |
| Metric | OBDC | SHC |
|---|---|---|
| Price | $11.35 | $15.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $14.28 | ★ $20.67 |
| AVG Volume (30 Days) | ★ 5.6M | 2.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 13.81% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | ★ 1.24 | 0.27 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | N/A | $6.00 |
| P/E Ratio | ★ $8.80 | $58.22 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $10.52 | $10.17 |
| 52 Week High | $15.19 | $19.85 |
| Indicator | OBDC | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.50 | 65.01 |
| Support Level | $11.07 | $15.19 |
| Resistance Level | $11.69 | $16.55 |
| Average True Range (ATR) | 0.32 | 0.43 |
| MACD | 0.04 | 0.31 |
| Stochastic Oscillator | 90.76 | 99.13 |
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.